• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经毒素诱导的帕金森病动物模型:发病机制与评估。

Neurotoxin-Induced Animal Models of Parkinson Disease: Pathogenic Mechanism and Assessment.

机构信息

1 College of Life Sciences, Institute for Conservation and Utilization of Agro-Bioresources in Dabie Mountains, Xinyang Normal University, China.

出版信息

ASN Neuro. 2018 Jan-Dec;10:1759091418777438. doi: 10.1177/1759091418777438.

DOI:10.1177/1759091418777438
PMID:29809058
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5977437/
Abstract

Parkinson disease (PD) is the second most common neurodegenerative movement disorder. Pharmacological animal models are invaluable tools to study the pathological mechanisms of PD. Currently, invertebrate and vertebrate animal models have been developed by using several main neurotoxins, such as 6-hydroxydopamine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, paraquat, and rotenone. These models achieve to some extent to reproduce the key features of PD, including motor defects, progressive loss of dopaminergic neurons in substantia nigra pars compacta, and the formation of Lewy bodies. In this review, we will highlight the pathogenic mechanisms of those neurotoxins and summarize different neurotoxic animal models with the hope to help researchers choose among them accurately and to promote the development of modeling PD.

摘要

帕金森病(PD)是第二常见的神经退行性运动障碍。药理学动物模型是研究 PD 病理机制的宝贵工具。目前,已经通过使用几种主要神经毒素(如 6-羟多巴胺、1-甲基-4-苯基-1,2,3,6-四氢吡啶、百草枯和鱼藤酮)开发了无脊椎动物和脊椎动物动物模型。这些模型在一定程度上再现了 PD 的关键特征,包括运动缺陷、黑质致密部多巴胺能神经元的进行性丧失以及路易体的形成。在这篇综述中,我们将重点介绍这些神经毒素的发病机制,并总结不同的神经毒性动物模型,希望能帮助研究人员准确选择,并促进 PD 模型的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6edf/5977437/933572086761/10.1177_1759091418777438-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6edf/5977437/1d95282f319d/10.1177_1759091418777438-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6edf/5977437/933572086761/10.1177_1759091418777438-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6edf/5977437/1d95282f319d/10.1177_1759091418777438-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6edf/5977437/933572086761/10.1177_1759091418777438-fig2.jpg

相似文献

1
Neurotoxin-Induced Animal Models of Parkinson Disease: Pathogenic Mechanism and Assessment.神经毒素诱导的帕金森病动物模型:发病机制与评估。
ASN Neuro. 2018 Jan-Dec;10:1759091418777438. doi: 10.1177/1759091418777438.
2
Experimental models of Parkinson's disease: Challenges and Opportunities.帕金森病的实验模型:挑战与机遇。
Eur J Pharmacol. 2024 Oct 5;980:176819. doi: 10.1016/j.ejphar.2024.176819. Epub 2024 Jul 18.
3
An Overview on the Role of α -Synuclein in Experimental Models of Parkinson's Disease from Pathogenesis to Therapeutics.α-突触核蛋白在帕金森病实验模型中从发病机制到治疗作用的概述
CNS Neurol Disord Drug Targets. 2016;15(10):1240-1252. doi: 10.2174/1871527315666160920160512.
4
Experimental models of chemically induced Parkinson's disease in zebrafish at the embryonic larval stage: a systematic review.斑马鱼胚胎幼虫期化学诱导帕金森病的实验模型:系统评价
J Toxicol Environ Health B Crit Rev. 2023 May 19;26(4):201-237. doi: 10.1080/10937404.2023.2182390. Epub 2023 Mar 1.
5
A guide to neurotoxic animal models of Parkinson's disease.帕金森病神经毒性动物模型指南。
Cold Spring Harb Perspect Med. 2011 Sep;1(1):a009316. doi: 10.1101/cshperspect.a009316.
6
Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.帕金森病1-甲基-4-苯基-1,2,3,6-四氢吡啶/丙磺舒渐进性神经退行性小鼠模型黑质致密部神经元凋亡的早期迹象。
Neuroscience. 2006 Jun 19;140(1):67-76. doi: 10.1016/j.neuroscience.2006.02.007. Epub 2006 Mar 14.
7
Application of neurotoxin- and pesticide-induced animal models of Parkinson's disease in the evaluation of new drug delivery systems.神经毒素和农药诱导的帕金森病动物模型在新型药物递送系统评估中的应用。
Acta Pharm. 2021 Aug 30;72(1):35-58. doi: 10.2478/acph-2022-0008. Print 2022 Mar 1.
8
Brain-derived neurotrophic factor expression in the substantia nigra does not change after lesions of dopaminergic neurons.多巴胺能神经元损伤后,黑质中脑源性神经营养因子的表达并未改变。
Neurotox Res. 2007 Sep;12(2):135-43. doi: 10.1007/BF03033922.
9
Chemically induced models of Parkinson's disease.帕金森病的化学诱导模型。
Comp Biochem Physiol C Toxicol Pharmacol. 2022 Feb;252:109213. doi: 10.1016/j.cbpc.2021.109213. Epub 2021 Oct 18.
10
Animal Models for Parkinson's Disease Research: Trends in the 2000s.帕金森病研究的动物模型:21 世纪的趋势。
Int J Mol Sci. 2019 Oct 30;20(21):5402. doi: 10.3390/ijms20215402.

引用本文的文献

1
MicroRNAs and synaptic dysfunction in Parkinson's disease.帕金森病中的微小RNA与突触功能障碍
Mol Ther Nucleic Acids. 2025 Aug 12;36(3):102673. doi: 10.1016/j.omtn.2025.102673. eCollection 2025 Sep 9.
2
Epigenetic regulation of the respiratory chain by a mitochondrial distress-related redox signal.线粒体应激相关氧化还原信号对呼吸链的表观遗传调控。
Front Cell Dev Biol. 2025 Aug 5;13:1608400. doi: 10.3389/fcell.2025.1608400. eCollection 2025.
3
Investigating Neuroprotective Effects of Berberine on Mitochondrial Dysfunction and Autophagy Impairment in Parkinson's Disease.

本文引用的文献

1
Metabolic Disturbances in the Striatum and Substantia Nigra in the Onset and Progression of MPTP-Induced Parkinsonism Model.MPTP诱导的帕金森病模型发病及进展过程中纹状体和黑质的代谢紊乱
Front Neurosci. 2018 Feb 20;12:90. doi: 10.3389/fnins.2018.00090. eCollection 2018.
2
Graded 6-OHDA-induced dopamine depletion in the nigrostriatal pathway evokes progressive pathological neuronal activities in the subthalamic nucleus of a hemi-parkinsonian mouse.6-羟基多巴胺诱导黑质纹状体通路中多巴胺逐渐耗竭,引发偏侧帕金森病小鼠丘脑底核进行性病理神经元活动。
Behav Brain Res. 2018 May 15;344:42-47. doi: 10.1016/j.bbr.2018.02.014. Epub 2018 Feb 13.
3
研究小檗碱对帕金森病线粒体功能障碍和自噬损伤的神经保护作用。
Int J Mol Sci. 2025 Jul 29;26(15):7342. doi: 10.3390/ijms26157342.
4
Comparative evaluation of MPTP and rotenone as inducing agents for Parkinson's disease in adult zebrafish: Behavioural and histopathological insights.MPTP和鱼藤酮作为成年斑马鱼帕金森病诱导剂的比较评价:行为学和组织病理学见解
Toxicol Rep. 2025 Jul 12;15:102084. doi: 10.1016/j.toxrep.2025.102084. eCollection 2025 Dec.
5
Understanding the Pre-Clinical Stages of Parkinson's Disease: Where Are We in Clinical and Research Settings?了解帕金森病的临床前期阶段:我们在临床和研究方面进展如何?
Int J Mol Sci. 2025 Jul 17;26(14):6881. doi: 10.3390/ijms26146881.
6
C18:0 GM3 ganglioside's efficacy in LPS-induced parkinsonism: neuroprotection, inflammatory inhibition and gliosis mitigation.C18:0 GM3神经节苷脂在脂多糖诱导的帕金森症中的功效:神经保护、炎症抑制和神经胶质增生缓解
Behav Brain Funct. 2025 Jul 26;21(1):25. doi: 10.1186/s12993-025-00289-8.
7
α-Synuclein Pathology in Synucleinopathies: Mechanisms, Biomarkers, and Therapeutic Challenges.突触核蛋白病中的α-突触核蛋白病理学:机制、生物标志物及治疗挑战
Int J Mol Sci. 2025 Jun 4;26(11):5405. doi: 10.3390/ijms26115405.
8
Reduced composite dietary antioxidant index increases the risk of Parkinson's disease and all-cause mortality in Parkinson's disease patients: evidence from the NHANES database.复合膳食抗氧化指数降低会增加帕金森病患者患帕金森病的风险及全因死亡率:来自美国国家健康与营养检查调查(NHANES)数据库的证据。
Front Aging Neurosci. 2025 Apr 17;17:1510654. doi: 10.3389/fnagi.2025.1510654. eCollection 2025.
9
Rescue of a Rotenone Model of Parkinson's Disease in by the Mitochondrial Na/Ca Exchanger Inhibitor CGP37157.线粒体钠钙交换体抑制剂CGP37157对帕金森病鱼藤酮模型的挽救作用
Int J Mol Sci. 2025 Apr 4;26(7):3371. doi: 10.3390/ijms26073371.
10
Advances in Zebrafish as a Comprehensive Model of Mental Disorders.斑马鱼作为精神疾病综合模型的研究进展
Depress Anxiety. 2023 Jun 20;2023:6663141. doi: 10.1155/2023/6663141. eCollection 2023.
Mutations in Caenorhabditis elegans neuroligin-like glit-1, the apoptosis pathway and the calcium chaperone crt-1 increase dopaminergic neurodegeneration after 6-OHDA treatment.
秀丽隐杆线虫神经胶质类似物 glit-1 中的突变、凋亡途径和钙伴侣 crt-1 增加了 6-OHDA 处理后的多巴胺能神经退行性变。
PLoS Genet. 2018 Jan 18;14(1):e1007106. doi: 10.1371/journal.pgen.1007106. eCollection 2018 Jan.
4
Pilot study: molecular risk factors for diagnosing sporadic Parkinson's disease based on gene expression in blood in MPTP-induced rhesus monkeys.初步研究:基于MPTP诱导的恒河猴血液基因表达诊断散发性帕金森病的分子危险因素
Oncotarget. 2017 Nov 10;8(62):105606-105614. doi: 10.18632/oncotarget.22348. eCollection 2017 Dec 1.
5
An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition.与线粒体复合物 I 抑制相关的帕金森运动缺陷的不良结局途径。
Arch Toxicol. 2018 Jan;92(1):41-82. doi: 10.1007/s00204-017-2133-4. Epub 2017 Dec 5.
6
Oral Exposure to Paraquat Triggers Earlier Expression of Phosphorylated α-Synuclein in the Enteric Nervous System of A53T Mutant Human α-Synuclein Transgenic Mice.口服百草枯会引发 A53T 突变型人α-突触核蛋白转基因小鼠肠神经系统中磷酸化α-突触核蛋白的早期表达。
J Neuropathol Exp Neurol. 2017 Dec 1;76(12):1046-1057. doi: 10.1093/jnen/nlx092.
7
Triggering of inflammasome by impaired autophagy in response to acute experimental Parkinson's disease: involvement of the PI3K/Akt/mTOR pathway.急性实验性帕金森病中自噬受损引发炎性小体:PI3K/Akt/mTOR通路的参与
Neuroreport. 2017 Oct 18;28(15):996-1007. doi: 10.1097/WNR.0000000000000871.
8
Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.慢性 MPTP 给药方案在猴子中的应用:帕金森病多巴胺能和非多巴胺能细胞丧失的模型。
J Neural Transm (Vienna). 2018 Mar;125(3):337-363. doi: 10.1007/s00702-017-1774-z. Epub 2017 Aug 31.
9
Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.人诱导多能干细胞衍生的多巴胺能神经元在灵长类帕金森病模型中发挥功能。
Nature. 2017 Aug 30;548(7669):592-596. doi: 10.1038/nature23664.
10
AF-6 Protects Against Dopaminergic Dysfunction and Mitochondrial Abnormalities in Models of Parkinson's Disease.AF-6可预防帕金森病模型中的多巴胺能功能障碍和线粒体异常。
Front Cell Neurosci. 2017 Aug 10;11:241. doi: 10.3389/fncel.2017.00241. eCollection 2017.